| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.045 | 0.4 |